Literature DB >> 1371157

Nonspecific oral immunity in individuals with HIV infection.

F Müller1, M Holberg-Petersen, H Rollag, M Degré, P Brandtzaeg, S S Frøland.   

Abstract

Lactoferrin, lysozyme, interferon, and neopterin levels were determined in parotid saliva from 44 individuals with different clinical stages of human immunodeficiency virus (HIV) infection and 19 HIV-seronegative controls. The secretory output of individual components was calculated according to the fluid flow rate. No parotid interferon activity was found in any of the HIV-infected subjects or controls, and no significant differences in parotid lysozyme or neopterin outputs were observed. The lactoferrin output was significantly decreased in HIV-seropositive subjects in parallel with their markedly reduced parotid secretory IgA output. This combined deficiency of parotid lactoferrin and secretory IgA may well contribute to the frequent oral infections seen in subjects with HIV infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371157

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  10 in total

Review 1.  Oral candidiasis, HIV, and saliva glucocorticoids.

Authors:  C O Enwonwu; V I Meeks
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 2.  Oral innate immunity in HIV infection in HAART era.

Authors:  Wipawee Nittayananta; Renchuan Tao; Lanlan Jiang; Yuanyuan Peng; Yuxiao Huang
Journal:  J Oral Pathol Med       Date:  2015-01-31       Impact factor: 4.253

3.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 4.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Oral fluids as an alternative to serum for measurement of markers of immune activation.

Authors:  P Nishanian; N Aziz; J Chung; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

6.  Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide.

Authors:  Laetitia Carthagena; Pierre Becquart; Hakim Hocini; Michel D Kazatchkine; Hicham Bouhlal; Laurent Belec
Journal:  Open Virol J       Date:  2011-04-15

Review 7.  HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation.

Authors:  Samantha E Heron; Shokrollah Elahi
Journal:  Front Immunol       Date:  2017-03-07       Impact factor: 7.561

8.  Effects of the common cold and intranasal fluticasone propionate treatment on mucosal host defense assessed by human saliva.

Authors:  M Lenander-Lumikari; T Puhakka; M J Mäkelä; P Vilja; O Ruuskanen; J Tenovuo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-06

9.  Salivary secretory immunoglobulin A reactivity: a comparison to cortisol and α-amylase patterns in the same breast cancer survivors.

Authors:  Maude Lambert; Marie-Ève Couture-Lalande; Kelly Brennan; Aldin Basic; Sophie Lebel; Catherine Bielajew
Journal:  Contemp Oncol (Pozn)       Date:  2018-09-30

10.  Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy.

Authors:  Shuang Li; Junping Zhu; Bin Su; Huanhuan Wei; Fei Chen; Hongshan Liu; Jiaqi Wei; Xiaodong Yang; Qiuyue Zhang; Wei Xia; Hao Wu; Qiushui He; Tong Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-07-14       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.